The pooled incidence of adverse drug events requiring ICU admission in adult patients was estimated at 7%, though this estimate was associated with high heterogeneity across studies.
Systematic Review (n=18,241)
What is the incidence and impact of adverse drug events requiring ICU admission in adult patients?
Adverse drug events are a significant cause of ICU admissions with high variability in reported incidence, mortality, and preventability, highlighting the need for standardized reporting.
Adverse drug events (ADE) may lead to hospital admission, and in some cases admission to an ICU is mandatory. We conducted a systematic review dealing with the incidence of ADE requiring ICU admission in adult patients, the reference population being all ICU admissions. Medline, Embase and Web of Science databases were screened from January 1982 to July 2014, using appropriate key words. Only original articles in English reporting the incidence of ADE requiring ICU admission in adult patients among total ICU admissions were included. Article eligibility was assessed by two independent reviewers, a third being involved in cases of disagreement. All reported characteristics (type of ICU, characteristics of patients, incidence of ADE, severity and preventability, drugs involved, causality) in the selected articles were collected for the review. The quality of studies was independently assessed by two reviewers with a specific score that we developed. A meta-analysis was conducted. Inclusion criteria were fulfilled by 11 studies out of the 4,311 identified in the initial literature search. The median (interquartile) quality score was 0.61 (0.44; 0.69). The reported incidences of ADE requiring ICU admission in adult patients ranged from 0.37 to 27.4%, with an associated mortality rate ranging from 2 to 28.1% and a mean length of stay ranging from 2.3 to 6.4 days. Preventable events accounted for 17.5 to 85.7% of the events. Costs and mechanisms at the root of ADE were investigated in only two and five studies, respectively. The forest plot examining the incidence of ADE requiring ICU admission in adult patients was associated with high heterogeneity (I (2) statistic > 98%), and the shape of the corresponding funnel plot was asymmetric. Heterogeneity across studies concerned many features, including studied populations, events considered, causality assessment methods, definitions of preventability and severity. Despite the heterogeneity of the reports, our review indicates that ICU admission due to ADE is a significant issue that should deserve further interest. The review led us to propose a list of items devoted to the reporting of future studies on ADE requiring ICU admissions.
Jolivot et al. (2014) conducted a systematic review in Adverse drug events requiring ICU admission (n=18,241). Adverse drug events vs. All ICU admissions was evaluated on Incidence of drug-related ICU admissions (IDRIA) (95% CI 6-8). The pooled incidence of adverse drug events requiring ICU admission in adult patients was estimated at 7%, though this estimate was associated with high heterogeneity across studies.